Login to Your Account



Financings Roundup


Friday, March 16, 2012
• Celldex Therapeutics Inc., of Needham, Mass., said underwriters of its public offering of common stock exercised in full their overallotment option to purchase an additional 1,575 million shares at $3.85 each.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription